Noveris Health Sciences is trading at $0.77, down 18.09%, after continued profit-taking following its sharp late-July run-up.
- The stock declined 12.96% on August 5, 2026.
- Recent coverage described it as highly volatile and thinly traded.
- No fresh company announcement or major catalyst was identified for August 6, 2026.